Stoyanova Lab awarded Department of Defense, Prostate Cancer Research Program, Idea Development Award for project title:
“Trop2 as a novel driver and therapeutic target for castration-resistant prostate cancer”
The proposed research aims to define new drives and therapeutic targets for advanced prostate cancer. We have recently demonstrated that cell surface protein, Trop2, represents a new promising therapeutic target for advanced prostate cancer. The proposed project will evaluate novel strategies to target Trop2 in aggressive prostate cancer. Identifying new therapeutic strategies and pathways and mechanisms that contribute to the development of aggressive prostate cancer will significantly advance the field of prostate cancer research.
Congratulations!
